Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1934 1
1938 1
1939 1
1949 1
1952 1
1956 5
1957 3
1958 2
1959 3
1960 2
1961 4
1962 5
1963 9
1964 10
1965 13
1966 8
1967 8
1968 7
1969 13
1970 8
1971 10
1972 7
1973 4
1974 5
1975 2
1976 9
1977 13
1978 14
1979 19
1980 28
1981 40
1982 30
1983 21
1984 29
1985 46
1986 45
1987 45
1988 36
1989 30
1990 35
1991 28
1992 40
1993 34
1994 43
1995 54
1996 44
1997 53
1998 47
1999 52
2000 56
2001 53
2002 68
2003 70
2004 81
2005 80
2006 82
2007 85
2008 108
2009 139
2010 148
2011 151
2012 220
2013 284
2014 276
2015 343
2016 317
2017 329
2018 307
2019 382
2020 422
2021 514
2022 549
2023 505
2024 539
2025 522
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,875 results

Results by year

Filters applied: . Clear all
Page 1
Nitrofuran-Based STING Inhibitors.
Barasa L, DeOrsey L, O'Reilly MD, Choudhary S, Cahill SE, Mathur A, Rajoria S, Green RM, Allabaji A, Nellikkalaya S, Paul S, Vidadala SR, Kumar Sarkar S, Patil SN, Hale J, Humphries F, Fitzgerald KA, Thompson PR. Barasa L, et al. Among authors: paul s. ACS Omega. 2025 Sep 4;10(36):41693-41706. doi: 10.1021/acsomega.5c05578. eCollection 2025 Sep 16. ACS Omega. 2025. PMID: 40978405 Free PMC article.
Staufen2 dysregulation in neurodegenerative disease.
Paul S, Dansithong W, Figueroa KP, Gandelman M, Hivare P, Scoles DR, Pulst SM. Paul S, et al. J Biol Chem. 2025 Mar;301(3):108316. doi: 10.1016/j.jbc.2025.108316. Epub 2025 Feb 13. J Biol Chem. 2025. PMID: 39955058 Free PMC article.
DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?
Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J; DALI Study. Roberts JA, et al. Among authors: paul sk. Clin Infect Dis. 2014 Apr;58(8):1072-83. doi: 10.1093/cid/ciu027. Epub 2014 Jan 14. Clin Infect Dis. 2014. PMID: 24429437
Commensal yeast promotes Salmonella Typhimurium virulence.
Jaswal K, Todd OA, Flores Audelo RC, Santus W, Paul S, Duffy CM, Eshoo ET 3rd, Singh M, Miao J, Underhill DM, Peters BM, Behnsen J. Jaswal K, et al. Among authors: paul s. Nature. 2025 Sep;645(8082):1002-1010. doi: 10.1038/s41586-025-09415-y. Epub 2025 Sep 3. Nature. 2025. PMID: 40903573 Free PMC article.
Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapy.
Roberts JA, Ulldemolins M, Liu X, Baptista JP, Bilgrami I, Boidin C, Brinkmann A, Castro P, Choi G, Cole L, De Waele JJ, Deans R, Donnellan S, Eastwood GM, Frey OR, Goutelle S, Gresham R, Jamal JA, Joynt GM, Kanji S, Kluge S, König C, Koulouras VP, Lassig-Smith M, Laterre PF, Lee A, Lefrant JY, Lei K, Leung P, Llaurado-Serra M, Martin-Loeches I, Nor MBM, Mudaliar Y, Ostermann M, Paul SK, Peake SL, Rello J, Roberts DM, Roberts MS, Richards B, Rodríguez A, Roehr AC, Roger C, Seoane L, Sinnollareddy M, Sousa E, Soy D, Spring A, Starr T, Stephens D, Taccone FS, Thomas J, Turnidge J, Valkonen M, Varghese JM, Wallis SC, Walker RJ, Williams T, Wilson LC, Wittebole X, Wright DFB, Zikou XT, Bellomo R, Lipman J; SMARRT Study Collaborators. Roberts JA, et al. Among authors: paul sk. Intensive Care Med. 2025 Sep;51(9):1628-1640. doi: 10.1007/s00134-025-08067-w. Epub 2025 Aug 13. Intensive Care Med. 2025. PMID: 40801954 Free PMC article.
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.
Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann HH, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Haljasmägi L, Migaud M, Särekannu K, Maslovskaja J, de Prost N, Tandjaoui-Lambiotte Y, Luyt CE, Amador-Borrero B, Gaudet A, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier JC, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux PL, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya JM, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs C, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, El Bakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, van de Beek D, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, K… See abstract for full author list ➔ Bastard P, et al. Among authors: paul s. Sci Immunol. 2021 Aug 19;6(62):eabl4340. doi: 10.1126/sciimmunol.abl4340. Sci Immunol. 2021. PMID: 34413139 Free PMC article.
6,875 results